Seeking Alpha

Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"

RESEARCH TRIANGLE PARK, N.C., May 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the clinical research industry-leading Metasite™, has been named the winner of the prestigious "Best ...

Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families

The MarketWatch News Department was not involved in the creation of this content. MORRISVILLE, N.C., March 17, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical ...
Seeking Alpha

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the industry-leading Metasite™, today announced the granting of inducement equity awards under the ...
Nasdaq

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today ...
FierceBiotech

Science 37 tapped for Synlogic's phase 3 trial of potential PKU treatment

Science 37 has been tapped to use its virtual clinical trial tech for phase 3 trials of Synlogic’s treatment for the rare genetic metabolic disorder phenylketonuria (PKU). Under the deal, Science 37’s ...
Business Wire

Science 37 and AOBiome Complete Industry-First Virtual Clinical Trial Through Metasite™ (Decentralized) Operating Model

PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clinical trials, announced today the completion of a Phase 2b study for AOBiome, a clinical-stage life ...
Nasdaq

Science 37 Acquires Vault Health’s Life Sciences Platform To Bolster its Metasite Capabilities

RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, announced today that it has acquired the life sciences platform ...
The Desert Sun

Science 37 Becomes First FDA-Inspected Site to Deliver Clinical Trials to Patients’ Homes

Science 37 is a leading patient access company in clinical research that delivers trials directly to patients’ homes. We go directly to the patient’s home, providing a seamless clinical trial ...
MarketWatch

Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards

The MarketWatch News Department was not involved in the creation of this content. MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical ...
The Herald-Sun

Morrisville tech firm leaves NC jobs deal, listing interest rates and layoffs

A Morrisville company that helps people participate in clinical trials from home through a software platform has exited its state incentive agreement to create 250 jobs in the Triangle, blaming ...
MobiHealthNews

Science 37 picks up $29 million more for remote clinical trials

Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Management with participation from Google's investment arm GV. One more new investor -- AmGen ventures - ...